280
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Serum urate at trial entry and ALS progression in EMPOWER

, , , , , , & show all
Pages 120-125 | Received 29 Mar 2016, Accepted 21 Jun 2016, Published online: 28 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hee Jo Han, Ha Young Shin, Young-Chul Choi, Seung Min Kim & Seung Woo Kim. (2022) Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone. Redox Report 27:1, pages 79-84.
Read now
Andrea Barp, Francesca Gerardi, Andrea Lizio, Valeria Ada Sansone & Christian Lunetta. (2020) Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials. Expert Opinion on Emerging Drugs 25:2, pages 145-164.
Read now
Éilis J. O’Reilly, Kjetil Bjornevik, Michael A. Schwarzschild, Marjorie L. McCullough, Laurence N. Kolonel, Loic Le Marchand, Joann E. Manson & Alberto Ascherio. (2018) Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 194-200.
Read now

Articles from other publishers (16)

Jiongming Bai, Xiaolan Zhang, Haoran Wang, Wenxiu Yu, Zhengqing He, Jiao Wang, Feng feng, Mao Li, Hongfen Wang, Fei Yang & Xusheng Huang. (2023) Gender-specific association of uric acid and survival in sporadic amyotrophic lateral sclerosis patients. Brain Research 1815, pages 148445.
Crossref
Fumihiro Takahashi, Osamu Kano, Yoshito Nagano, Takatomo Yoneoka, Sally Nelson & Yoshiteru Ushirogawa. (2022) Associations between the ALSFRS‐R score and urate levels during 12 months of edaravone treatment for amyotrophic lateral sclerosis: Post hoc analysis of ALSFRS‐R scores in clinical studies MCI186 ‐16, MCI186 ‐17, and MCI186 ‐19 . Muscle & Nerve 66:5, pages 593-602.
Crossref
Débora Lanznaster, Giulia Dingeo, Rayhanatou Altine Samey, Patrick Emond & Hélène Blasco. (2022) Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases. Metabolites 12:9, pages 864.
Crossref
Giana Kristy Ramos & David S. Goldfarb. (2022) Update on Uric Acid and the Kidney. Current Rheumatology Reports 24:5, pages 132-138.
Crossref
Michail S. Kukharsky, Veronika I. Skvortsova, Sergey O. Bachurin & Vladimir L. Buchman. (2020) In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches. Medicinal Research Reviews 41:5, pages 2804-2822.
Crossref
Shotaro Haji, Wataru Sako, Nagahisa Murakami, Yusuke Osaki, Takahiro Furukawa, Yuishin Izumi & Ryuji Kaji. (2021) The value of serum uric acid as a prognostic biomarker in amyotrophic lateral sclerosis: Evidence from a meta-analysis. Clinical Neurology and Neurosurgery 203, pages 106566.
Crossref
Liu-Qing Xu, Wei Hu, Qi-Fu Guo, Guo-Rong Xu, Ning Wang & Qi-Jie Zhang. (2021) Serum Uric Acid Levels Predict Mortality Risk in Male Amyotrophic Lateral Sclerosis Patients. Frontiers in Neurology 12.
Crossref
Ovidiu C. Andronesi, Katharine Nicholson, Kourosh Jafari-Khouzani, Wolfgang Bogner, Jing Wang, James Chan, Eric A. Macklin, Mark Levine-Weinberg, Christopher Breen, Michael A. Schwarzschild, Merit Cudkowicz, Bruce R. Rosen, Sabrina Paganoni & Eva-Maria Ratai. (2020) Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients. Frontiers in Neurology 11.
Crossref
Namita A. Goyal, James D. Berry, Anthony Windebank, Nathan P. Staff, Nicholas J. Maragakis, Leonard H. van den Berg, Angela Genge, Robert Miller, Robert H. Baloh, Ralph Kern, Yael Gothelf, Chaim Lebovits & Merit Cudkowicz. (2020) Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle & Nerve 62:2, pages 156-166.
Crossref
Snežana Spasić, Aleksandra Nikolić-Kokić, Srđan Miletić, Zorana Oreščanin-Dušić, Mihajlo B. Spasić, Duško Blagojević & Zorica Stević. (2020) Edaravone May Prevent Ferroptosis in ALS. Current Drug Targets 21:8, pages 776-780.
Crossref
Solmaz Yazdani, Daniela Mariosa, Niklas Hammar, John Andersson, Caroline Ingre, Göran Walldius & Fang Fang. (2019) Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow‐up. Annals of Neurology 86:6, pages 913-926.
Crossref
Kjetil Bjornevik, Zhongli ZhangÉilis J. O'ReillyJames D. BerryClary B. Clish, Amy DeikSarah JeanfavreIkuko KatoRachel S. KellyLaurence N. KolonelLiming LiangLoic Le MarchandMarjorie L. McCulloughSabrina PaganoniKerry A. PierceMichael A. SchwarzschildAladdin H. ShadyabJean Wactawski-WendeDong D. WangYing WangJoAnn E. MansonAlberto Ascherio. (2019) Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 92:18.
Crossref
Katharine Nicholson, James Chan, Eric A. Macklin, Mark Levine‐Weinberg, Christopher Breen, Rachit Bakshi, Daniela L. Grasso, Anne‐Marie Wills, Samad Jahandideh, Albert A. Taylor, Danielle Beaulieu, David L. Ennist, Ovidiu Andronesi, Eva‐Maria Ratai, Michael A. Schwarzschild, Merit Cudkowicz & Sabrina Paganoni. (2018) Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 5:12, pages 1522-1533.
Crossref
Rachit Bakshi, Yuehang Xu, Kaly A. Mueller, Xiqun Chen, Eric Granucci, Sabrina Paganoni, Ghazaleh Sadri-Vakili & Michael A. Schwarzschild. (2018) Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1 mutant mice. Molecular and Cellular Neuroscience 92, pages 12-16.
Crossref
Sabrina Paganoni, Katharine Nicholson, James Chan, Amy Shui, David Schoenfeld, Alexander Sherman, James Berry, Merit Cudkowicz & Nazem Atassi. (2018) Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database. Muscle & Nerve 57:3, pages 430-434.
Crossref
Fan Zhang, Qin Zhang, Yaqiong Ke, Jianbo Hao, Ling Lu, Nannan Lu & Xiling Chen. (2018) Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis. Scientific Reports 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.